Thymocyte selection-associated high mobility group box gene (TOX) is aberrantly over-expressed in mycosis fungoides and correlates with poor prognosis
about
TOX gene: a novel target for human cancer gene therapyEctopic expression of embryonic stem cell and other developmental genes in cutaneous T-cell lymphomaTOX acts an oncological role in mycosis fungoides.The Use of Transcriptional Profiling to Improve Personalized Diagnosis and Management of Cutaneous T-cell Lymphoma (CTCL).Staphylococcal enterotoxin A (SEA) stimulates STAT3 activation and IL-17 expression in cutaneous T-cell lymphomaTOX expression and role in CTCL.TOX expression in cutaneous T-cell lymphomas: an adjunctive diagnostic marker that is not tumour specific and not restricted to the CD4(+) CD8(-) phenotype.Gene expression analysis in Cutaneous T-Cell Lymphomas (CTCL) highlights disease heterogeneity and potential diagnostic and prognostic indicators.TruSeq-Based Gene Expression Analysis of Formalin-Fixed Paraffin-Embedded (FFPE) Cutaneous T-Cell Lymphoma Samples: Subgroup Analysis Results and Elucidation of Biases from FFPE Sample Processing on the TruSeq Platform.TOX expression in cutaneous B-cell lymphomas.Analysis of CTCL cell lines reveals important differences between mycosis fungoides/Sézary syndrome vs. HTLV-1+ leukemic cell lines.Immunohistopathological Study of c-FLIP Protein in Mycosis FungoidesDifferential expression of TOX by skin-infiltrating T cells in Sézary syndrome and erythrodermic dermatitis.TOX expression in different subtypes of cutaneous lymphoma.
P2860
Q26765220-93C2346F-EB69-4035-A459-A614B92E4D90Q35201911-5BBC5E50-8687-42A3-9EAB-C74A63FE32AFQ35219716-DCF1696F-3271-4B7D-AB08-E82BBE43F649Q35752062-55A47052-1034-4409-AE8A-4BF02FAE02E0Q36675064-DA20703B-26DA-417C-83C5-ADAF0438C587Q39654084-E3AE55C9-A75E-4A4A-9191-DC1163920620Q39956410-DD4FE020-A141-4541-9838-1F29CFD7ED23Q40150337-DC095B54-8110-46FE-AE47-8C75F491CCF7Q42270898-EB8A5B32-885B-4C85-B430-195FE352EE60Q42426124-72040638-23A7-4662-B282-2C7DB27AF3E5Q47100819-0B105F64-54C4-49B2-AD22-DA4570B9499AQ47139624-DD4A718D-22BD-4256-904A-68890FB1FFCDQ53581753-3B0F9554-E6CE-40F8-846B-7FA756815EFCQ54191987-69123878-9830-4880-8484-0C810E37FE78
P2860
Thymocyte selection-associated high mobility group box gene (TOX) is aberrantly over-expressed in mycosis fungoides and correlates with poor prognosis
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Thymocyte selection-associated ...... correlates with poor prognosis
@ast
Thymocyte selection-associated ...... correlates with poor prognosis
@en
Thymocyte selection-associated high mobility group box gene
@nl
type
label
Thymocyte selection-associated ...... correlates with poor prognosis
@ast
Thymocyte selection-associated ...... correlates with poor prognosis
@en
Thymocyte selection-associated high mobility group box gene
@nl
prefLabel
Thymocyte selection-associated ...... correlates with poor prognosis
@ast
Thymocyte selection-associated ...... correlates with poor prognosis
@en
Thymocyte selection-associated high mobility group box gene
@nl
P2093
P2860
P356
P1433
P1476
Thymocyte selection-associated ...... correlates with poor prognosis
@en
P2093
Denis Sasseville
Ivan V Litvinov
Jan P Dutz
Ming-Wan Su
Thomas S Kupper
Xiaoyan Jiang
Youwen Zhou
Yuanshen Huang
P2860
P304
P356
10.18632/ONCOTARGET.2031
P407
P577
2014-06-01T00:00:00Z